MAP2K7 and melanoma: The hypothesis of melanoma addiction to the RAF/MEK/ERK pathway, namely the MAPK pathway, emerged with the discovery of a high frequency of the BRAFV600E-activating mutation in melanoma cell lines and primary tumors [1].